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Associations of Perirenal Fat Thickness with Renal and 
Systemic Calcified Atherosclerosis
Bo Kyung Koo1,2, Julie O. Denenberg3, C. Michael Wright3, Michael H. Criqui3, Matthew A. Allison3
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul; 2Department of Internal Medicine, 
Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea; 3Department of Family 
Medicine and Public Health, University of California San Diego, La Jolla, CA, USA
Background: We investigated associations between perirenal fat thickness and atherosclerotic calcification in six different vascular 
beds.
Methods: Using a community-based cohort (n=3,919), perirenal fat thickness was estimated from computed tomography scans. It 
was classified as Q1 (the lowest quartile) to Q4 (the highest quartile) in each sex. Calcification in the carotid arteries, coronary arter-
ies, thoracic aorta, abdominal aorta, iliac arteries, and renal arteries was evaluated.
Results: Perirenal fat thickness was associated with older age (P<0.01) and a higher prevalence of obesity, hypertension, and dys-
lipidemia (P<0.01 for all). Perirenal fat thickness was independently associated with renal arterial calcification even after adjust-
ment for age, sex, body mass index, hypertension, dyslipidemia, smoking history, and family history of heart diseases in first-degree 
relatives (odds ratio [OR] per quartile of perirenal fat thickness, 1.25; 95% confidence interval [CI], 1.09 to 1.44). Compared to Q1, 
the odds of renal arterial calcification in Q4 was about two times higher (OR, 2.05; 95% CI, 1.29 to 3.25). After adjustment for renal 
arterial calcification and atherosclerotic risk factors, the only other vascular bed where perirenal fat thickness showed a significant 
association with calcification was the abdominal aorta (OR, 1.11; 95% CI, 1.00 to 1.23; P=0.045).
Conclusion: Perirenal fat thickness was independently associated with vascular calcification in the renal artery and abdominal aorta.
Keywords: Atherosclerosis; Vascular calcification; Obesity; Renal artery; Aorta, abdominal  
INTRODUCTION
Visceral fat, intrahepatic fat, and intramuscular fat are involved 
in lipid and glucose metabolism and contribute to the develop-
ment of metabolic abnormalities [1-5]. They also cause lipotox-
icity and inflammation [6-8], and consequently, atherosclerosis 
[1,8-10].
Perirenal fat has the same developmental origins as visceral 
fat [11]. It is associated not only with waist circumference and 
metabolic syndrome [12], but also with the risk of hypertension 
[13] and chronic kidney disease [14]. However, few studies 
have investigated the association between perirenal fat thick-
ness and systemic atherosclerosis. In addition, since renal sinus 
fat has been reported to exert a local effect on the renin-angio-
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tensin-aldosterone system [15,16], perirenal fat might have dif-
ferent associations with atherosclerosis in other arterial beds de-
pending on their location.
Perirenal fat thickness was assessed by computed tomography 
(CT), which has been reported to be a reliable method of mea-
suring perirenal fat volume [17]. In the current study, we investi-
gated the association between perirenal fat thickness and arterial 
calcification using a large community-based cohort that was 
evaluated for the extent of calcified atherosclerosis in six differ-
ent vascular beds: the carotid arteries, coronary arteries, thoracic 
aorta, abdominal aorta, iliac arteries, and renal arteries. In addi-
tion, differences in the association between perirenal fat and vas-
cular calcification among different arterial beds were evaluated.
METHODS
Study population
From October 1999 to July 2003, 9,763 asymptomatic subjects 
visited a university-affiliated disease prevention center in San 
Diego, California and had a CT scan for preventive health 
screening [10]. Most subjects were self-referred or referred by 
their primary care provider. The study protocol conformed to 
the ethical guidelines of the 1975 Declaration of Helsinki and 
was reviewed and approved by the Institutional Review Board 
(IRB) of the University of California, San Diego, Human Re-
search Protections Program (IRB number: 150603). All subjects 
provided informed consent.
For the current study, we analyzed subjects who had CT scans 
of the carotid arteries, coronary arteries, thoracic aorta, abdomi-
nal aorta, iliac arteries, and renal arteries (n=4,671). To mini-
mize confounders between ectopic fat and systemic atheroscle-
rosis, subjects with diabetes mellitus [18] or a history of coro-
nary bypass, cardiac or carotid stent, or stroke were excluded 
(n=577). After additionally excluding subjects with intra-ab-
dominal masses on their CT scans (n=98) or with a poor-quality 
CT scan in terms of perirenal fat on both sides (n=77), 3,919 
subjects were included in the analysis.
Clinical and laboratory assessments
Before undergoing the scanning procedure, a questionnaire was 
used to obtain medical history, current medications, smoking his-
tory, and family history of cardiovascular diseases. Height and 
weight were measured using a stadiometer and standardized 
scale. From these measurements, body mass index (BMI) was 
calculated as kilograms divided by meters squared (kg/m2) and 
obesity was defined as a BMI ≥30 kg/m2 [19]. Systolic and dia-
stolic blood pressure measurements were obtained by a trained 
technician after the participant rested for 5 minutes. Hypertension 
was defined as systolic blood pressure >140 mm Hg, diastolic 
blood pressure >90 mm Hg, or the use of anti-hypertensive med-
ications. Casual serum lipid and glucose levels were obtained via 
a finger-stick using the Cholestech LDX system (Alere, Hay-
ward, CA, USA). Dyslipidemia was defined as a ratio of total to 
high-density lipoprotein cholesterol (HDL-C) of >5, or the use 
of cholesterol-lowering medication. Diabetes mellitus was identi-
fied by the current use of anti-diabetic medications or a casual 
serum glucose level ≥200 mg/dL. Smoking status was classified 
as current smokers, ex-smokers, and never-smokers.
Imaging
The determination of quantitative calcium scores in various ar-
terial beds has been described previously [10,20-22]. Briefly, all 
participants underwent imaging with an Imatron C-150 scanner 
(GE Imatron, San Francisco, CA, USA). Each bed was obtained 
by a distinct scan of the segment in question using the following 
slice thicknesses: 3 mm for the coronary bed; 6 mm through the 
neck, abdomen, and pelvis; and 5 mm for the thorax. Cardiac 
tomographic imaging was performed with electrocardiogram-
gated triggering. The coronary artery calcium score was calcu-
lated according to the method described by Agatston et al. [23]. 
Atherosclerotic calcification was defined as a plaque of ≥2 pix-
els (area=0.67 mm2) with a density of ≥130 Hounsfield units. 
Data from the left and right sides were combined to give the ex-
tent of calcium in the carotid, iliac, and renal arterial beds.
On CT scans, perirenal fat thickness was evaluated as the dis-
tance from the kidney to the nearest viscera or muscle, and five 
perirenal measurements were taken (medial, posterior, lateral, 
anterolateral, and posterolateral) on a slice passing through the 
renal vein (Supplemental Fig. S1) [17,24,25]. All five measure-
ments were made on both sides for each patient. One reader 
measured the scans blinded to the demographic data. The repro-
ducibility of the measurements was examined using 50 random-
ly selected participant scans, for which intra-reader variability 
was assessed by calculating the intraclass correlation coefficient 
(ICC) [26]. The ICCs for perirenal fat thickness were 0.984 
(95% confidence interval [CI], 0.972 to 0.991; P<0.01) and 
0.872 (95% CI, 0.785 to 0.925; P<0.01) for the left and right 
kidney, respectively. The total perirenal fat thickness was de-
fined as the sum of perirenal fat thickness on both sides, and it 
was classified as Q1 (the lowest quartile) to Q4 (the highest 
quartile) in each sex, as males have more perirenal fat than fe-
males (Supplemental Table S1) [24].
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Statistical analysis
Patients’ clinical characteristics according to the quartiles of 
perirenal fat thickness were compared using analysis of vari-
ance or the Kruskal-Wallis test for continuous variables and the 
chi-square test for categorical variables. To investigate indepen-
dent factors determining the presence of calcification, a binary 
logistic regression model was generated with adjustment for 
age, sex, hypertension, dyslipidemia, obesity, current smoking 
status, and family history of heart diseases in first-degree rela-
tives. A receiver operating characteristic curve was used to eval-
uate the diagnostic performance of the detection of arterial bed 
calcification, and values of the area under the receiver operating 
characteristic curve (AUROC) were compared using the boot-
strap method (n=1,000). P values <0.05 were considered to in-
dicate statistical significance. All statistical analyses were con-
ducted using SPSS version 24.0 (IBM Inc., Armonk, NY, USA) 
and the R 3.5.3. program (http://www.R-project.org; Vienna, 
Austria). 
RESULTS
Clinical characteristics according to perirenal fat thickness 
on CT
The mean age of the sample was 56±11 years, and 55.6% were 
male (Table 1). The prevalence of arterial calcification was 53.3% 
in the coronary arteries, 26.2% in the carotid arteries, 34.8% in 
the thoracic aorta, 52.4% in the abdominal aorta, 47.1% in the ili-
ac arteries, and 12.5% in the renal arteries (9.2% and 8.3% in 
the left and right renal arteries, respectively). Among all sub-
jects with renal arterial calcification (n=488), 198 (40.6%) had 
calcification in both renal arteries, 126 (25.8%) in the right kid-
ney only, and 164 (33.6%) in the left kidney only. The median 
total perirenal fat thickness was 13.0 cm (interquartile range 
[IQR], 8.1 to 18.4) and 5.3 cm (IQR, 3.4 to 8.1) in males and fe-
males, respectively (Supplemental Table S1). There was a 
strong correlation between right and left perirenal fat thickness 
(Spearman ρ=0.866; P<0.001).
Increasing perirenal fat thickness was associated with older 
age (mean age 50.4±10.3, 54.7±10.4, 57.4±10.7, and 60.6±
10.2 years in Q1 to Q4, respectively; P<0.01) and more severe 
obesity (median BMI, 23.9 kg/m2 [IQR, 21.9 to 26.0], 26.0 kg/
m2 [IQR, 23.5 to 28.0], 27.0 kg/m2 [IQR, 25.0 to 29.8], and 29.9 
kg/m2 [IQR, 27.0 to 32.3], respectively; P<0.01). The preva-
lence of obesity, hypertension, and dyslipidemia also increased 
as perirenal fat thickness increased (P<0.01) (Table 1). In the 
crude analysis, a significant association was found between 
perirenal fat thickness quartiles and vascular calcification in 
each arterial bed (P<0.01 in all arterial beds) (Table 1).
Prevalence of arterial calcification according to perirenal 
fat thickness
In the crude analysis, as perirenal fat thickness increased by 
quartile, the odds of coronary and carotid calcification increased 
(odds ratio [OR], 1.386; 95% CI, 1.308 to 1.468; and OR, 
1.520; 95% CI, 1.420 to 1.627, respectively) (Table 2). Calcifi-
cation in the thoracic aorta, abdominal aorta, iliac arteries, and 
renal arteries also showed significant associations with perirenal 
fat thickness (Table 2). After adjustment for age, sex, BMI, hy-
pertension, HDL-C, non-HDL-C, smoking history, and family 
history of heart disease in first-degree relatives, only vascular 
calcification in the coronary, carotid, and renal arteries were sig-
nificantly associated with perirenal fat thickness (model 2 in Ta-
ble 2). Specifically, renal arterial calcification was independent-
ly associated with perirenal fat in this model (OR per quartile of 
perirenal fat thickness, 1.251; 95% CI, 1.091 to 1.435) (model 2 
in Table 2). Moreover, compared to Q1, the odds of renal arteri-
al calcification increased along with perirenal fat thickness, with 
ORs of 1.399 (95% CI, 0.893 to 2.191; P=0.142), 1.786 (95% 
CI, 1.153 to 2.768; P=0.009), and 2.050 (95% CI, 1.294 to 
3.250; P=0.002) for Q2 to 4, respectively (Table 2, Fig. 1A, 
Supplemental Table S2). Similarly, the ORs for carotid artery, 
thoracic aorta, and abdominal aorta calcification for each in-
crease in the perirenal fat thickness quartile were modest, but 
significant: 1.118 (95% CI, 1.006 to 1.241; P=0.037), 1.141 
(95% CI, 1.030 to 1.264; P=0.011), and 1.117 (95% CI, 1.013 
to 1.23; P=0.027), respectively (Table 2, Fig. 1A). 
A sensitivity analysis according to sex also confirmed the sig-
nificance of the association between perirenal fat thickness and 
renal artery calcification in both sexes (Supplemental Table S3). 
A significant association between perirenal fat thickness and ar-
terial calcification was not found in both sexes for any arterial 
bed other than the renal artery (Supplemental Table S3). 
The risk of renal arterial calcification on each side was evalu-
ated according to the ipsilateral and contralateral perirenal fat 
thickness. No location-specific differences in the association 
between renal arterial calcification and perirenal fat thickness 
were found (Supplemental Table S4), and the AUROC values 
for the prediction of renal arterial calcification by the ipsilateral 
and contralateral perirenal fat thickness were similar (Supple-
mental Table S5). The AUROC for the prediction of renal artery 
calcification using total perirenal fat was higher than the AU-
ROCs obtained when using either the contralateral fat or ipsilat-
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Table 1. Clinical Characteristics of the Study Subjects According to Perirenal Fat Thickness 
Characteristic Q1 (n=979) Q2 (n=981) Q3 (n=980) Q4 (n=979) P valuea
Age, yr 50.4±10.3 54.7±10.4 57.4±10.7 60.6±10.2 <0.001
Men 544 (55.6) 544 (55.6) 544 (55.6) 544 (55.6) 1.000
Body mass index, kg/m2 23.9 (21.9–26.0) 26.0 (23.5–28.0) 27.0 (25.0–29.8) 29.0 (27.0–32.3) <0.001
SBP, mm Hg 118 (108–128) 122 (112–136) 124 (116–136) 130 (120–140) <0.001
DBP, mm Hg 76 (68–82) 78 (70–84) 80 (72–84) 80 (74–86) <0.001
Total cholesterol, mg/dL 196 (174–221) 202 (178–228) 209 (182–235) 208 (183–233) <0.001
HDL-C, mg/dL 55 (43–69) 51 (40–66) 52 (41–64) 49 (39–59) <0.001
Triglycerides, mg/dL 112 (79–167) 135 (93–196) 145 (101–198) 164 (117–234) <0.001
LDL-C, mg/dL 115 (92–137) 117 (94–143) 122 (98–146) 122 (99–144) <0.001
Hypertension 200 (20.4) 341 (34.8) 374 (38.2) 509 (52.0) <0.001
Dyslipidemia (n=3,458) 207 (24.0) 318 (36.9) 351 (39.8) 410 (48.1) <0.001
Obesity 61 (6.5) 144 (15.2) 250 (26.1) 427 (45.1) <0.001
Smoker
   Ex-smoker 265 (27.1) 299 (30.5) 365 (37.1) 343 (35.0) 0.140b
   Current smoker 103 (10.5) 89 (9.1) 85 (8.7) 77 (7.9)
Medications
   Anti-platelet agents 60 (6.1) 77 (7.8) 93 (9.5) 102 (10.4) <0.001
   Lipid-lowering agents 72 (7.4) 103 (10.5) 137 (14.0) 160 (16.3) <0.001
   Anti-hypertensive drugs 64 (6.5) 121 (12.3) 151 (15.4) 227 (23.2) <0.001
Arterial calcification
   Coronary artery 396 (40.4) 494 (50.4) 567 (57.9) 632 (64.6) <0.001
   Carotid artery (n=3,479) 144 (16.4) 225 (25.9) 292 (34.0) 366 (41.8) <0.001
   Thoracic aorta 206 (21.0) 290 (29.6) 376 (38.4) 490 (50.1) <0.001
   Abdominal aorta 344 (35.1) 489 (49.8) 573 (58.5) 648 (66.2) <0.001
   Iliac artery 323 (33.0) 440 (44.9) 503 (51.3) 578 (59.0) <0.001
   Renal artery 47 (4.8) 95 (9.7) 144 (14.7) 202 (20.6) <0.001
Values are expressed as mean±standard deviation, number (%), or median (interquartile range). Hypertension was defined as SBP >140 mm Hg, DBP 
>90 mm Hg, or the use of anti-hypertensive medications. Dyslipidemia was defined as a ratio of total to HDL-C >5, or the use of cholesterol-lowering 
medication. 
SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
aUsing analysis of variance for age, the Kruskal-Wallis test for the other continuous variables, and the chi-square test for categorical variables; bFrom lin-
ear-by-linear association.
Table 2. Risk of Arterial Calcification According to Perirenal Fat Thickness (per Quartile)
Variable
Unadjusted Age and sex–adjusted Model 1 Model 2
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Coronary artery 1.386 (1.308–1.468) <0.001 1.162 (1.088–1.240) <0.001 1.083 (1.01–1.171) 0.047 1.079 (0.990–1.176) 0.082
Carotid artery 1.520 (1.420–1.627) <0.001 1.162 (1.074–1.258) <0.001 1.115 (1.016–1.224) 0.022 1.118 (1.006–1.241) 0.037
Thoracic aorta 1.548 (1.455–1.647) <0.001 1.096 (1.014–1.184) 0.021 1.156 (1.053–1.268) 0.002 1.141 (1.030–1.264) 0.011
Abdominal aorta 1.522 (1.436–1.614) <0.001 1.077 (1.001–1.159) 0.046 1.136 (1.041–1.240) 0.004 1.117 (1.013–1.233) 0.027
Iliac artery 1.414 (1.335–1.498) <0.001 1.056 (0.985–1.131) 0.125 1.042 (0.959–1.132) 0.327 1.012 (0.924–1.110) 0.793
Renal artery 1.666 (1.519–1.827) <0.001 1.227 (1.104–1.365) <0.001 1.289 (1.137–1.460) <0.001 1.251 (1.091–1.435) 0.001
Model 1: with adjustment for age, sex, and body mass index. Model 2: with adjustment for hypertension, high-density lipoprotein cholesterol (HDL-C), 
non-HDL-C, smoking history, and family history of heart disease in first-degree relatives in addition to Model 1.
OR, odds ratio; CI, confidence interval.
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Fig. 1. The risk of arterial calcification according to the quartiles of perirenal fat thickness. Total perirenal fat thickness was defined as the sum 
of perirenal fat thickness of both sides, and it was classified as Q1 (the lowest quartile) to Q4 (the highest quartile). Odds ratios (ORs) with 
95% confidence interval (CIs) of the calcification in each arterial bed according to the perirenal fat thickness are shown (A) in the entire popu-
lation, (B) those without renal artery calcification, and (C) in those with renal artery calcification. All statistical values were adjusted for age, 
sex, body mass index, hypertension, high-density lipoprotein cholesterol (HDL-C), non-HDL-C, smoking history, and family history of heart 
disease in first-degree relatives. RACS, renal artery calcification score. aP<0.05 compared to Q1; bP<0.005 compared to Q1; cP for trend.
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eral fat, although there was no statistically significant differ-
ence. In females, the AUROC of right perirenal fat thickness for 
the prediction of left renal arterial calcification was significantly 
lower than that of total perirenal fat thickness (P=0.008); how-
ever, it was not significantly different from that of left perirenal 
fat thickness (P=0.452). Similarly, the AUROC of left perirenal 
fat thickness for the prediction of right renal arterial calcifica-
tion was lower than that of total perirenal fat thickness (P=  
0.006) in females (Supplemental Table S5).
Calcification in different arterial beds according to the 
status of renal arterial calcification
Since renal arterial calcification itself is a well-known risk fac-
tor for both hypertension and systemic atherosclerosis [27], and 
because a strong association between renal fat thickness and re-
nal arterial calcification was found in the current study (Fig. 
1A), the association between perirenal fat thickness and vascu-
lar calcification in the other arterial beds was re-evaluated ac-
cording to the presence or absence of renal arterial calcification 
(Fig. 1B, C). In subjects with renal arterial calcification, the 
prevalence of vascular calcification in each arterial bed reached 
>70% irrespective of perirenal fat thickness (Table 3). Even in 
Q1, the prevalence of vascular calcification in the coronary ar-
teries, carotid arteries, thoracic aorta, and abdominal aorta was 
83.0%, 70.7%, 74.5%, and 93.6%, respectively. No significant 
association was found between the prevalence of arterial calcifi-
cation and perirenal fat thickness in those with renal arterial cal-
cification after adjustment for confounders (Table 3). 
Table 4. Risk of Arterial Calcification According to Perirenal Fat Thickness (per Quartile) in Subjects without Renal Artery Calcification
Variable
Unadjusted Age and sex–adjusted Model 1 Model 2
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Coronary artery 1.329 (1.250–1.413) <0.001 1.155 (1.079–1.237) <0.001 1.076 (0.991–1.169) 0.080 1.082 (0.989–1.185) 0.086
Carotid artery 1.437 (1.330–1.554) <0.001 1.146 (1.051–1.250) 0.002 1.059 (0.956–1.174) 0.273 1.056 (0.940–1.186) 0.360
Thoracic aorta 1.426 (1.330–1.528) <0.001 1.050 (0.966–1.141) 0.249 1.105 (1.000–1.222) 0.050 1.098 (0.982–1.227) 0.100
Abdominal aorta 1.424 (1.339–1.516) <0.001 1.065 (0.988–1.147) 0.099 1.122 (1.026–1.228) 0.012 1.109 (1.003–1.228) 0.045
Iliac artery 1.321 (1.242–1.406) <0.001 1.028 (0.957–1.105) 0.449 1.002 (0.918–1.093) 0.972 0.979 (0.889–1.079) 0.671
Model 1: with adjustment for age, sex, and body mass index. Model 2: with adjustment for hypertension, high-density lipoprotein cholesterol (HDL-C), 
non-HDL-C, smoking history, and family history of heart diseases in the first-degree relatives in addition to Model 1.
OR, odds ratio; CI, confidence interval.
Table 3. Prevalence of Vascular Calcification According to Perirenal Fat Thickness 
Variable Q1 Q1 Q3 Q4 P valuea P valueb
Renal artery calcification (–) 932 886 836 777
   Coronary artery 357 (38.3) 414 (46.7) 450 (53.8) 460 (59.2) <0.001 0.086
   Carotid artery (n=3,032c) 115 (13.8) 168 (21.4) 195 (26.9) 227 (33.1) <0.001 0.360
   Thoracic aorta 171 (18.3) 208 (23.5) 249 (29.8) 307 (39.5) <0.001 0.100
   Abdominal aorta 300 (32.2) 398 (44.9) 432 (51.7) 454 (58.4) <0.001 0.045
   Iliac artery 284 (30.5) 360 (40.6) 380 (45.5) 396 (51.0) <0.001 0.671
Renal artery calcification (+) 47 95 144 202
   Coronary artery 39 (83.0) 80 (84.2) 117 (81.3) 172 (85.1) 0.701 0.237
   Carotid artery (n=447d) 29 (70.7) 57 (67.9) 97 (73.5) 139 (73.2) 0.475 0.212
   Thoracic aorta 35 (74.5) 82 (86.3) 127 (88.2) 183 (90.6) 0.008 0.254
   Abdominal aorta 44 (93.6) 91 (95.8) 141 (97.9) 194 (96.0) 0.551 0.244
   Iliac artery 39 (83.0) 80 (84.2) 123 (85.4) 182 (90.1) 0.089 0.456
Values are expressed as number(%).
aP for trend, unadjusted; bP for trend with adjustment for age, sex, body mass index, hypertension, high-density lipoprotein cholesterol (HDL-C), non-
HDL-C, smoking history, and family history of heart disease in first-degree relatives; cNumber of subjects in each quartile: 836, 785, 726, and 685 in Q1, 
Q2, Q3, and Q4, respectively; dNumber of subjects in each quartile: 41, 84, 132, and 190 in Q1, Q2, Q3, and Q4, respectively.
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By contrast, in subjects without renal arterial calcification, a 
significant trend in the prevalence of arterial calcification ac-
cording to perirenal fat thickness was found (P<0.001 for all in 
the crude analysis) (Table 3). Subsequent adjustment for age, 
sex, BMI, hypertension, HDL-C, non-HDL-C, smoking history, 
and family history of heart disease in first-degree relatives atten-
uated the statistical significance of these trends. Only abdominal 
aorta calcification remained significant (P for trend=0.045) (Ta-
ble 3). For each 1-quartile increase in perirenal fat thickness, the 
odds of abdominal aorta calcification increased by 10% (OR, 
1.109; 95% CI, 1.003 to 1.228; P=0.045) (model 2 in Table 4). 
The ORs for abdominal aorta calcification in Q2, Q3, and Q4 
compared to Q1 were 1.305 (95% CI, 1.010 to 1.305; P=0.042), 
1.357 (95% CI, 1.029 to 1.791; P=0.031), and 1.393 (95% CI, 
1.013 to 1.916; P=0.041), respectively (Fig. 1B). 
DISCUSSION
The results of the current study suggest that perirenal fat thick-
ness is significantly associated with the presence of renal arteri-
al calcification. Even after adjustment for atherosclerotic risk 
factors such as age, obesity, dyslipidemia, hypertension, smok-
ing history, and family history, the risk of renal arterial calcifica-
tion increased by 25% with every quartile of perirenal fat thick-
ness. Perirenal fat thickness was also associated with calcified 
atherosclerosis in the other vascular beds evaluated (the carotid 
arteries, coronary arteries, thoracic aorta, abdominal aorta, iliac 
arteries, and renal arteries); however, after adjustment for renal 
arterial calcification and atherosclerotic risk factors, it was only 
associated with abdominal aorta calcification. 
Perirenal fat is, like other ectopic fat, an active secretory or-
gan that produces adipokines and cytokines [28,29], which in-
duce inflammation [6-8], and consequently, atherosclerosis [1,8-
10]. The current findings that perirenal fat thickness was signifi-
cantly associated not only with dyslipidemia or hypertension, 
but also with systemic arterial calcification, and that the signifi-
cant association between vascular calcification and perirenal fat 
thickness was attenuated by adjustment for atherosclerotic risk 
factors, suggest a systemic effect of perirenal fat on the athero-
sclerotic process. Nevertheless, the presence of an independent 
association between renal artery calcification and perirenal fat 
thickness in a dose-dependent manner suggests that perirenal fat 
exerts a local effect on the renal arteries. Furthermore, in fe-
males, the prediction of renal artery calcification by contralater-
al perirenal fat thickness was less powerful than the use of total 
perirenal fat thickness. Perirenal fat is known to induce a local 
inflammatory response [30] and to regulate renal physiology 
[30,31]. Nonetheless, no significant difference was found in the 
effect of perirenal fat thickness between the ipsilateral and con-
tralateral renal arteries in the current study. The AUROC for the 
prediction of renal artery calcification using total perirenal fat 
was higher than the AUROC values obtained for both the con-
tralateral fat and ipsilateral fat, even though the difference did 
not reach statistical significance. We could not differentiate fat 
inside the renal fascia from the fat outside the fascia, which may 
have attenuated the local effects of perirenal fat. Considering 
that renal sinus fat increases renal hydrostatic pressure and acti-
vates the renin-angiotensin-aldosterone system [15,16], fat in-
side the renal fascia might have a more direct effect on the renal 
arteries than perirenal fat outside the fascia. In addition, in the 
current study, both perirenal fat thickness and renal arterial cal-
cification on both sides were strongly correlated with each oth-
er, which might have caused the absence of a difference be-
tween the ipsilateral and contralateral associations. Further 
studies to determine the local effects of perirenal fat are needed. 
Renal arterial calcification is an independent risk factor for 
all-cause mortality even in healthy outpatients without any car-
diovascular disease [27]. A stratified analysis according to the 
presence of renal arterial calcification in the current study con-
firmed that the presence of renal artery calcification reflects a 
high risk of systemic atherosclerosis. Specifically, the preva-
lence of vascular calcification in the other arterial beds among 
those with renal artery calcification was more than 70% in each 
arterial bed, irrespective of the amount of perirenal fat. By con-
trast, in those without renal arterial calcification, a significant 
trend in the prevalence of arterial calcification according to 
perirenal fat thickness was found in all arterial beds in the crude 
analysis, which implies that the effects of ectopic fat such as 
perirenal fat might be different according to the severity of the 
systemic atherosclerosis burden, and that reduction of ectopic 
fat might have a more favorable effect on cardiometabolic 
health in the early stages of atherosclerosis.
Interestingly, in those without renal arterial calcification, the 
only independent association between vascular calcification and 
perirenal fat thickness was found for abdominal aorta calcifica-
tion, although its OR per quartile was around 1.2. Currently, it is 
not apparent why perirenal fat thickness was independently as-
sociated with calcification in the abdominal aorta, but not in the 
other vascular beds. The prevalence of calcification in abdomi-
nal aorta and coronary arteries was relatively high compared to 
the other arteries in the current study, which might have 
strengthened the statistical significance of this finding despite 
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the similar ORs. In addition, the relatively short anatomical dis-
tance between perirenal fat and the abdominal aorta might have 
contributed to this finding, and this possibility should be ex-
plored in another independent study. 
A limited number of studies have estimated perirenal fat 
thickness using CT scans [17,24]. In most previous studies, 
perirenal fat thickness was assessed using ultrasonography [12-
14]. Although ultrasonography is more convenient, CT scans 
enable a full-scale measurement [32]. In addition, perirenal fat 
thickness assessed by CT scans was reported to be a reliable 
marker of perirenal fat volume [17]. 
The current study has several limitations. First, as mentioned 
above, we did not differentiate fat inside the renal fascia from 
the fat outside the fascia, which might have masked the local ef-
fects of perirenal fat. Few studies have compared the effects of 
fat on both sides. Although both pararenal fat [13] as well as re-
nal sinus fat [33,34] have been reported to be independent risk 
factors for hypertension even after adjustment for visceral fat, 
the fat inside the renal fascia might exert a more direct effect on 
the renal arteries than the perirenal fat outside the fascia via the 
renin-angiotensin-aldosterone system [15,16] and local inflam-
mation [8]. Second, we did not measure waist circumference or 
intra-abdominal visceral fat, although a comparison of the effect 
of perirenal fat to that of other visceral fat on systemic athero-
sclerotic calcification would enable the pathophysiological role 
of perirenal fat distinct from other visceral fat to be elucidated. 
In addition, no information on fasting lipid levels was analyzed 
in the current study. However, the ratio of total to HDL-C 
[35,36] and non-HDL-C [37] used in the current study has been 
reported to be a good predictor of future cardiovascular diseas-
es. Lastly, the cross-sectional nature of the study makes it im-
possible to identify the causal relationships underlying the asso-
ciation between perirenal fat and arterial calcification. 
A major strength of the study is that the current findings are 
based on a large community-based cohort that underwent exten-
sive evaluations of systemic calcification, including six arterial 
beds in each of 3,919 subjects. Furthermore, few previous stud-
ies have investigated the association between perirenal fat thick-
ness and systemic atherosclerotic calcification. 
In the current study, we confirmed that perirenal fat thickness 
was independently associated with vascular calcification in the 
renal artery and abdominal aorta. Further epidemiological stud-
ies to replicate the current findings are needed in diverse study 
populations. 
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